Coronary Artery Bypass Grafting Market Forecasted to Grow at 6.1% CAGR, Reaching USD 18,234 Million by 2033

Coronary Artery Bypass Grafting Market Forecasted to Grow at 6.1% CAGR, Reaching USD 18,234 Million by 2033
Coronary Artery Bypass Grafting Market – Latest Scenario and Future Aspect Analysis by 2033
Coronary Artery Bypass Grafting Market is projected to Reach around USD 18,234 Million by 2033, growing at a CAGR of 6.1% from 2023 to 2033.

Coronary Artery Bypass Grafting Market is projected to achieve a value of USD 12,753 Million in 2023, with a linear behavior in the market growth it is forecasted to achieve a value of USD 18,234 Million by 2033 with a CAGR of 6.1% during the forecast period 2023-2033.

CABG is a procedure used to treat diseases related to coronary artery. Coronary artery is carried essential nutrients and vitamins through the blood to the heart muscles. Coronary artery diseases related with the narrowing the artery due to saturation of fatty material on the inner wall of artery. Causes the barrier to supply of blood to the heart muscles.

Coronary Artery Bypass Grafting surgery is surgery to improve and restore the supply of blood to the heart muscles. Positive reimbursement programs, the global prevalence of various coronary heart diseases, a lack of physical activity and unhealthy dietary habits, and continuous progress in surgical methods all contribute to propelling the growth of coronary artery bypass grafting market in forecasted period.

Request Free Sample Copy of this Report@ https://wemarketresearch.com/reports/request-free-sample-pdf/coronary-artery-bypass-grafting-market/1347

Market Dynamics

The growth of the worldwide market for coronary artery bypass graft devices can be attributed to the surge in cases of cardiovascular diseases, primarily linked to factors such as obesity, diabetes, and hypertension. For instance, cardiovascular disease stands as a leading global cause of mortality, as reported by the WHO’s 2021 factsheet. In 2019, nearly 17.9 million individuals lost their lives to this condition, with 75 percent of these deaths occurring in low- and middle-income countries.

Furthermore, the technologically advanced Coronary Artery Bypass Grafting launched by various market players is also anticipated to enhance the growth the coronary artery bypass grafting market. For instance, according to a study published in January 2023 issue of the Journal of Thoracic and Cardiovascular Surgery, the application of a robotic platform is employed for conducting minimally invasive coronary artery bypass grafting (CABG). MICS CABG is an approach that employs smaller incisions and less invasive techniques for performing the surgery. This results in reduced hospital stays, less pain and quicker recovery periods.

Moreover, despite the many growth acceptances some factors restrain the growth like CABG is a complex surgical intervention procedure with inherent risks of success and acceptance, along with involving a significant cost of procedure included hospitalization, surgical fees, and follow-up care limit the coronary artery bypass grafting market growth.

Overall, with the help of existing and modern treatment therapy the CABG Market is expected to witness significant growth in the coming years, driven by the introduction of new therapies and an increasing demand for effective treatments.

Market By Procedure Analysis

By Procedure, the Coronary Artery Bypass Grafting market is Categories into Single CABG Surgery, Double CABG Surgery, Triple CABG Surgery, Quadruple CABG Surgery and Others. The Single CABG Surgery segment accounts for the largest share of around 37% in 2022.

The significant growth can be attributed to factors such as effectively restores blood flow to the heart muscle, reducing the risk of heart attacks and improving long-term survival. Moreover, Single CABG can be performed with minimally invasive techniques, leading to smaller incisions and shorter hospital stays. Additionally, it allows for customized treatment, tailoring the procedure to individual patient needs. After surgery, patients often require fewer medications and experience an overall improvement in their cardiac health, making it a valuable option for those with severe coronary artery disease.

Secure A Copy Of The Premium Research Report@ https://wemarketresearch.com/purchase/coronary-artery-bypass-grafting-market/1347?license=single

Market By Surgery Type Analysis

By Surgery Type, the Coronary Artery Bypass Grafting market is Categories Off-Pump, On-Pump, Minimally Invasive Direct CABG, and Others. The Off-Pump segment accounts for the largest share of around 54% of the market in 2022.

The increase in this trend can be linked to the advantages linked with this approach, including reduced hospitalization durations, smaller surgical openings, and quicker recuperation. Furthermore, it diminishes the likelihood of various complications after surgery, such as infections, irregular heartbeats, and inflammation. Additionally, it provides improved alternatives for individuals with cirrhosis, chronic respiratory issues, and kidney ailments.

Market End User Analysis

By End-user, the Coronary Artery Bypass Grafting market is Categories into Hospitals, Cardiology Clinics, Research Institutes and Others. The Hospital segment accounts for the largest share of around 54% in 2022. Rising investment in healthcare and increasing hospital facility in developed and developing country are major factor to drive the segment. Increasing prevalence of cardiovascular diseases and COVID-19 is one more additional factor which helps to dominate the segment.

Related Reports

Duck Medicine and Vaccines Market

High Level Disinfection Services Market

Lupus Therapeutics Market

Morphine, Buprenorphine, and Other Drugs Market

Pharmaceutical Aseptic Fill & Finish CMO Market

Competitive Analysis

The Coronary Artery Bypass Grafting market is dominated by a few large companies, such as Dextera Surgical Inc., NOVADAQ Technologies Inc., VasoPrep Surgical,Terumo Cardiovascular Systems Corporation, Neograft Inc., MAQUET Holding B.V. & Co. KG., Hancock Jaffe Laboratories, Inc., Genesee BioMedical,  Boston Scientific, Edwards Lifesciences Corporation, Sorin Group and Others.

About We Market Research:

WE MARKET RESEARCH is an established market analytics and research firm with a domain experience sprawling across different industries. We have been working on multi-county market studies right from our inception. Over the time, from our existence, we have gained laurels for our deep-rooted market studies and insightful analysis of different markets.

Media Contact
Company Name: We Market Research
Contact Person: Mr. Robin
Email: Send Email
Country: United States
Website: https://wemarketresearch.com/reports/coronary-artery-bypass-grafting-market/1347